+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 47108

Chapter 47108 contains a list of PDF Full Texts available from EurekaMag.





Zhou, J.H., 1996:
Prospects on the development of traditional Chinese drugs in the new century

Stockx, L.; Wilms, G.; Baert, A.L., 1997:
Prospects with renal artery stenting

Grubman, M.J.; Mason, P.W., 2003:
Prospects, including time-frames, for improved foot and mouth disease vaccines

Fisher, G.; Pappas, G.; Limb, M., 1996:
Prospects, problems, and prerequisites for national health examination surveys in developing countries

Manner, P.A.; Rubash, H.E.; Herndon, J.H., 1999:
Prospectus. Future trends in transfusion

Jay, V.; Meniere, P., 2000:
Prosper Menière

Morrison, A.W.; Meniere, P., 1997:
Prosper Ménière (1799-1862). A synopsis of his life and times

Latkowski, B.; Chaberski, J.; M��ni��re, P., 1997:
Prosper Ménière: unknown and little known facts

Hoffman, P., 1997:
Prospering under PPS. A guide for financial managers

Loudon, I., 1987:
Prosperity and poverty in general practice 1750-1850

Palombo, S.R., 1995:
Prospero's Books: the unconscious visualized

Hildebrand, P., 2002:
Prospero's paper

Schleiner, W.; Shakespeare, W., 1987:
Prospero, as a Renaissance therapist

Burke, H.B.; Bostwick, D.G., 1998:
ProstAsure Index in the detection of prostate cancer

Friederich, M.; Theurer, C.; Schiebel-Schlosser, G., 2000:
Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients

Higgs, E.A.; Higgs, G.A.; Moncada, S.; Vane, J.R.; Higgs, E.A.; Higgs, G.A.; Moncada, S.; Vane, J.R., 1997:
Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977

Scheeren, T.; Radermacher, P., 1997:
Prostacyclin (PGI2): new aspects of an old substance in the treatment of critically ill patients

Su, Z.; Li, Y.J.; Yan, X.D.; Chen, X., 1994:
Prostacyclin analog (cicaprost) protects against damage by hydrogen peroxide to rabbit cardiac sarcoplasmic reticulum

Wang, M.; Sakon, M.; Miyoshi, H.; Umeshita, K.; Kishimoto, S.; Taniguchi, K.; Gotoh, M.; Imajoh-Ohmi, S.; Monden, M., 1998:
Prostacyclin analog-suppressed ischemia-reperfusion injury of the rat liver: evaluation by calpain mu activation

Chen, M.F.; Chen, J.C.; Chiu, D.F.; Ng, C.J.; Shyr, M.H.; Chen, H.M., 2002:
Prostacyclin analogue (OP-2507) induces delayed ex vivo neutrophil apoptosis and attenuates reperfusion-induced hepatic microcirculatory derangement in rats

Izzat, M.B.; Taylor, T.; Holt, C.M.; Angelini, G.D., 1996:
Prostacyclin analogues

Olschewski, H.; Walmrath, D.; Schermuly, R.; Ghofrani, H.A.; Grimminger, F.; Seeger, W., 1998:
Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension

Shio, H., 2000:
Prostacyclin and its metabolites

Suzuki, H.; Fujimoto, N.; Miyoshi, T.; Shio, H., 1995:
Prostacyclin and metabolites

Bieroń, K.; Grodzińska, L.; Kostka-Trabka, E.; Gryglewski, R.J., 1993:
Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease

Wu, K.K., 1997:
Prostacyclin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis

Maksimović, Z.V., 2000:
Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities

Rich, S., 1994:
Prostacyclin and primary pulmonary hypertension

Varela-Aguilar, J.M.; Sánchez-Hueso, M.C.; González-Jimenez, M.D.; García-Contreras, R.F.; González dela Puente, M.A., 1997 :
Prostacyclin and risk of thromboembolism

Benigni, A.; Remuzzi, G., 2000:
Prostacyclin and thromboxane and the development of preeclampsia

Ritter, J.M.; Brett, S.E.; Woods, J.D.; Benjamin, N.; Stratton, P.D.; Barrow, S.E., 1996:
Prostacyclin biosynthesis in essential hypertension before and during treatment

Jahr, J.; Grände, P.O., 1996:
Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha

Paramothayan, N.S.; Lasserson, T.J.; Wells, A.U.; Walters, E.H., 2002:
Prostacyclin for pulmonary hypertension

Kaur, K.; Brown, B.; Lombardo, F., 2000:
Prostacyclin for secondary pulmonary hypertension

Katircioğlu, S.F.; Bayazit, M.; Taşdemir, O.; Bayazit, K., 1996:
Prostacyclin for spinal cord protection during aortic occlusion

Scheeren, T.; Susanto, F.; Reinauer, H.; Tarnow, J.; Radermacher, P., 1994:
Prostacyclin improves glucose utilization in patients with sepsis

Sinzinger, H., 2001:
Prostacyclin in portopulmonary hypertension

Series, C.; Level, C.; Guez, S.; Morel, D.; Vincent, M.P.; Bigourdan, V.; Fabry, V.; Dutronc, H.; Potaux, L., 1996:
Prostacyclin in the treatment of hemolytic-uremic syndrome: apropos of a case

Nielsen, H.R.; Jensen, B.F.; Heslet, L., 1998 :
Prostacyclin inhalation in pulmonary failure following smoke inhalation

Tran, H.S.; Quinn, J.V.; Puc, M.M.; Woolley, D.S.; Puglisi, R.N.; Slotman, G.J., 2001:
Prostacyclin is neither sufficient alone nor necessary to cause pulmonary dysfunction: results from infusions of prostacyclin and antiprostacyclin antibody in porcine septic shock

Mei, X.; Gu, Z., 1997:
Prostacyclin participates in regulation of hypoxic and high CO2 cerebrovascular tension

Restifo, R.J.; Dumanian, G.A.; Garrett, K.O.; Hong, C.; Johnson, P.C., 1996:
Prostacyclin production at the human microvascular anastomosis: its effect on initial platelet deposition

Bentzer, P.; Holbeck, S.; Grände, P.O., 2000:
Prostacyclin reduces microvascular fluid conductivity in cat skeletal muscle through opening of ATP-dependent potassium channels

Koyama, T.; Kakishita, E., 1993:
Prostacyclin stability in thrombotic thrombocytopenic purpura. Japan Working Group on TTP

Hirawa, N.; Umemura, S., 2000:
Prostacyclin synthase gene; nonsense mutation and the gene therapy

Johnston, D.E., 1994:
Prostacyclin synthesis in heart transplant recipients

Ram, R.; Levy, Y.; Shoenfeld, Y., 2000:
Prostacyclin--its function and indications for therapeutic use

Hatae, T.; Wada, M.; Yokoyama, C.; Shimonishi, M.; Tanabe, T., 2001:
Prostacyclin-dependent apoptosis mediated by PPAR delta

Zellers, T.M.; Wu, Y.Q.; McCormick, J.; Vanhoutte, P.M., 2001:
Prostacyclin-induced relaxations of small porcine pulmonary arteries are enhanced by the basal release of endothelium-derived nitric oxide through an effect on cyclic GMP-inhibited-cyclic AMP phosphodiesterase

Rodríguez-García, J.L.; Villa, E.; Serrano, M.; Gallardo, J.; García-Robles, R., 2000:
Prostacyclin: its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism

Benvenuto, D.B., 2000:
Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension

Pereszlenyi, A.; Harustiak, S.; Klepetko, W., 2002:
Prostacyclins in pulmonary hypertension treatment

Thavarasah, A.S.; Sivalingam, N., 1988:
Prostaglandin (F2 alpha) and missed abortion

Freitas, T.R.; Caldas, L.A.; Rebello, M.A., 1999:
Prostaglandin A1 inhibits replication of classical swine fever virus

Boller, Y.C.; Brandes, L.M.; Russell, R.L.; Lin, Z.P.; Patierno, S.R.; Kennedy, K.A., 2001:
Prostaglandin A1 inhibits stress-induced NF-kappaB activation and reverses resistance to topoisomerase II inhibitors

Kim, I.K.; Lee, J.H.; Sohn, H.W.; Kim, H.S.; Kim, S.H., 1993:
Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells

Hayaishi, O., 1997:
Prostaglandin D synthase, beta-trace and sleep

Urade, Y.; Watanabe, K.; Hayaishi, O. , 1995:
Prostaglandin D, E, and F synthases

Uehara, Y., 2000:
Prostaglandin D2

Fouchécourt, S.; Castella, S.; Dacheux, Fçoise.; Dacheux, J-Louis., 2002:
Prostaglandin D2 synthase secreted in the caput epididymidis displays spatial and temporal delay between messenger RNA and protein expression during postnatal development

Avakian, S.A.; Boiadzhian, A.S.; Pogosian, A.G.; Karagezian, K.G., 1994:
Prostaglandin D2-synthase from cattle brain: purification and physico-chemical properties

Bochenek, G.; Nagraba, K.; Gielicz, A.; Szczeklik, A., 2002:
Prostaglandin D2: biosynthesis, biological properties and participation in bronchial asthma

Grieve, W.G.; Johnson, G.K.; Moore, R.N.; Reinhardt, R.A.; DuBois, L.M., 1994:
Prostaglandin E (PGE) and interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during human orthodontic tooth movement

Beno, D.W.A..; Davis, B.H.., 1995:
Prostaglandin E Suppresses Hepatic Fibrosis: Section I. The In Vivo Approach; Section II. The In Vitro Approach

Platz-Christensen, J.J.; Pernevi, P.; Bokström, H.; Wiqvist, N., 1997:
Prostaglandin E and F2 alpha concentration in the cervical mucus and mechanism of cervical ripening

Davydov, R.R.; Fokina, A.N.; Zhukov, V.P.; Davidovich, G.M., 1993:
Prostaglandin E in acute viral hepatitis

Asbóth, G.; Phaneuf, S.; López Bernal, A.L., 1997:
Prostaglandin E receptors in myometrial cells

Murakami, M.; Nakatani, Y.; Tanioka, T.; Kudo, I., 2002:
Prostaglandin E synthase

Kurie, J.M.; Dubois, R.N., 2001:
Prostaglandin E synthase: another enzyme in the cyclooxygenase pathway driving epithelial cancer?

Sato, T.; Asanuma, Y.; Kurokawa, T.; Kato, T.; Yasui, O.; Kusano, T.; Koyama, K., 2000:
Prostaglandin E(1) continuous hepatic arterial infusion in the treatment of postoperative acute liver failure: basic study on hepatic hemodynamics and clinical application

Locker, G.J.; Grimm, M.; Losert, H.; Stoiser, B.; Kofler, J.; Knapp, S.; Wilfing, A.; Knoebl, P.; Kapiotis, S.; Czerny, M.; Muhm, M.; Hiesmayr, M.; Frass, M., 2000:
Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting

Dell, K.; Böhler, T.; Gaedeke, J.; Budde, K.; Neumayer, H.H.; Waiser, J., 2001:
Prostaglandin E(1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells

Stout, T.A.E.; Allen, W.R., 2002:
Prostaglandin E(2) and F(2 alpha) production by equine conceptuses and concentrations in conceptus fluids and uterine flushings recovered from early pregnant and dioestrous mares

Faour, W.H.; He, Y.; He, Q.W.; de Ladurantaye, M.; Quintero, M.; Mancini, A.; Di Battista, J.A., 2001:
Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts

Matveeva, V.A., 2001:
Prostaglandin E(2) release by human and Syrian hamster tumor cells and their sensitivity to cytostatic activity of natural killers

Vita, R.; Schall-Napier, A.; Oppenheimer-Marks, N., 1995 :
Prostaglandin E(2)-Mediated Inhibition of the Transendothelial Migration of Human T Lymphocytes

McLaren, J.; Taylor, D.J.; Bell, S.C., 2000:
Prostaglandin E(2)-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes

Dumais, N.; Bounou, S.; Olivier, M.; Tremblay, M.J., 2001:
Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5'-monophosphate response element binding protein

Derouet, H.; Weirauch, A.; Bewermeier, H., 1996:
Prostaglandin E1 (PGE1) in diagnosis and long-term therapy of erectile dysfunction

Koch, J.A.; Plum, J.; Grabensee, B.; Mödder, U., 1999:
Prostaglandin E1 (PGE1)--prophylaxis against radiocontrast-induced nephrotoxicity in patients with pre-existing renal dysfunction. PGE1 Study Group

Somberg, J.C.; Yelamanchi, V.; Molnar, J.; Aschermann, M.; Bernink, P.J.; Caspi, A.; Marmor, A.; Rabinowitz, B.; Reisin, L.; Ruzyllo, W., 1999:
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators

Hasegawa, S.; Imamura, M.; Shimada, Y.; Kanda, Y.; Wada, H.; Hitomi, S.; Mori, K., 1996:
Prostaglandin E1 ameliorates decreased tracheal blood flow after esophagectomy and aggressive upper mediastinal lymphadenectomy for esophageal carcinoma

Ray, J.G., 1998:
Prostaglandin E1 analogs do not improve renal function among either transplant or nontransplant patients: no further trials required

Merkus, P.J.; Cromme-Dijkhuis, A.H.; Robben, S.G.; Hess, J., 1993:
Prostaglandin E1 and gastric outlet obstruction in infants

Shio, H.; Fujimoto, N.; Miyoshi, T.; Suzuki, H., 1995:
Prostaglandin E1 and its metabolites

Johnson, R.G., 2000:
Prostaglandin E1 and myocardial reperfusion injury

Yukioka, H.; Asada, K.; Fujimori, M.; Shimazu, A., 1993:
Prostaglandin E1 as a hypotensive drug during general anesthesia for total hip replacement

Tamura, D.Y.; Moore, E.E.; Partrick, D.A.; Johnson, J.L.; Offner, P.J.; Silliman, C.C., 1998:
Prostaglandin E1 attenuates cytotoxic mechanisms of primed neutrophils

Nakaseko, C.; Oh, H.; Kogure, K.; Ishii, A.; Ishii, H.; Ikegami, T.; Kawano, E.; Nishimura, M.; Matsuura, Y.; Morio, S., 1993:
Prostaglandin E1 bladder instillations for a patient with severe hemorrhagic cystitis after allogeneic bone marrow transplantation

Fraccaro, A.; Grion, A.M.; Gaion, R.M.; Ricatti, M.G.; Pescatori, E.S.; Calabrò, A., 1993:
Prostaglandin E1 diluted solution: preparation technique and stability evaluation

Shechter, M.; Agranat, O.; Har-Zahav, Y.; Rath, S.; Kaplinsky, E.; Rabinowitz, B., 1999:
Prostaglandin E1 during angioplasty as preventative therapy for coronary restenosis

Mayumi, H.; Tokunaga, K., 1993:
Prostaglandin E1 for patients who have both heart and lung failure after cardiotomy

Candela-Toha, A.M.; Martiínez-Perez, A.; Liano, F., 1999:
Prostaglandin E1 for renal function preservation in transplant patients: no further trials required

Morioka, D.; Kubota, T.; Sekido, H.; Matsuo, K.; Saito, S.; Ichikawa, Y.; Endo, I.; Togo, S.; Shimada, H., 2003:
Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation

Adachi, N.; Ochi, T.; Tabo, E.; Nagaro, T.; Arai, T., 2001:
Prostaglandin E1 improves hepatic encephalopathy produced by ischaemia-reperfusion liver injury in rats

Kuwert, C.; Abeck, D.; Steinkraus, V.; Jakob, T.; Ring, J., 1995:
Prostaglandin E1 improves necrobiosis lipoidica

Polyak, M.M.; Arrington, B.O.; Stubenbord, W.T.; Kinkhabwala, M., 1998:
Prostaglandin E1 improves pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys

Saxena, A.; Sharma, M.; Kothari, S.S.; Juneja, R.; Reddy, S.C.; Sharma, R.; Bhan, A.; Venugopal, P., 1999:
Prostaglandin E1 in infants with congenital heart disease: Indian experience

Armstrong, D.K.; Convery, A.; Dinsmore, W.W., 1994:
Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic

Wasler, A.; Iberer, F.; Tscheliessnigg, K.H.; Auer, T.; Petutschnigg, B., 1993:
Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension

Desvaux, P.; Mimoun, S., 1994:
Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies

Xu, H.S.; Rosenlof, L.K.; Pruett, T.L.; Jones, R.S., 1994:
Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation

Pioruńska-Stolzmann, M., 2000 :
Prostaglandin E1 influences serum cholesterol esterase and lipase activity in different ways

Weiss, J.M.; Pilarski, K.A.; Weyl, A.; Peschen, M.; Schöpf, E.; Vestweber, D.; Vanscheidt, W.; Simon, J.C., 1995:
Prostaglandin E1 inhibits TNF alpha-induced T-cell adhesion to endothelial cells by selective down-modulation of ICAM-1 expression on endothelial cells

Schneider, A.; Thaiss, F.; Rau, H.P.; Wolf, G.; Zahner, G.; Jocks, T.; Helmchen, U.; Stahl, R.A., 1996:
Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta

Hauck, E.W.; Altinkilic, B.M.; Schroeder-Printzen, I.; Rudnick, J.; Weidner, W., 2000:
Prostaglandin E1 long-term self-injection programme for treatment of erectile dysfunction--a follow-up of at least 5 years

Hashimoto, Y.; Hirota, K.; Ohtomo, N.; Sato, T.; Ishihara, H.; Matsuki, A., 2000:
Prostaglandin E1 produces spasmolytic effects on histamine-induced bronchoconstriction in dogs

Natori, S.; Fujii, Y.; Kurosawa, H.; Nakano, A.; Shimada, H., 1998:
Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells

Huk, I.; Brovkovych, V.; Nanobashvili, J.; Neumayer, C.; Polterauer, P.; Prager, M.; Patton, S.; Malinski, T., 2000:
Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release

Kawamura, T.; Nara, N.; Kadosaki, M.; Inada, K.; Endo, S., 2000:
Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery

Hollenbeck, M.; Dinter, K.; Torsello, G.; Koch, M.; Willers, R.; Sandmann, W.; Grabensee, B., 1999:
Prostaglandin E1 reduces the risk of delayed graft function after cadaveric renal transplantation

Pignone, A.; Generini, S.; Matucci Cerinic, M., 2001:
Prostaglandin E1 restores the levels of vWF and ACE in chronic critical limb ischemia in systemic sclerosis

Yegen, C.; Aktan, A.O.; Yalcin, S.; Yalin, R., 1995:
Prostaglandin E1 treatment

Hashiba, Y.; Ishikawa, K.; Kosaki, H.; Ito, H.; Watanabe, A.; Miwa, S.; Fujimura, Y.; Kimura, T.; Ishizuka, T.; Kazeto, S., 1994:
Prostaglandin E1 treatment for severe preeclampsia after cesarean section and during vaginal delivery

Wang, Z-Lin.; Li, B.; Yan, J-Zhong.; Dong, S-Guo., 2002:
Prostaglandin E1 versus sildenafil in the management of erectile dysfunction

Meinhardt, W.; de la Fuente, R.B.; Lycklama à Nijeholt, A.A.; Vermeij, P.; Zwartendijk, J., 1996:
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction

Shio, H., 2000:
Prostaglandin E1, E2 and their metabolites

Kuzhikandathil, E.V.; Molloy, G.R., 1995:
Prostaglandin E1, E2, and cholera toxin increase transcription of the brain creatine kinase gene in human U87 glioblastoma cells

Pacher, R.; Stanek, B.; Hülsmann, M.; Berger, R.; Siegel, A.; Daneschvar, H.; Rödler, S.; Frey, B.; Grimm, M.; Laufer, G., 1997:
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results

de Boccard, G.A.; Rochat, C.H., 1993:
Prostaglandin E1--the pharmacologic prosthesis

Fujita, N., 1993:
Prostaglandin E1-induced hypotension: its effect on rate of cerebrospinal fluid formation in anesthetized cats

Koch, J.A.; Plum, J.; Grabensee, B.; Mödder, U., 1999:
Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group

Reddy, S.C.; Saxena, A., 2000:
Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects

Guseva, N.G., 2001:
Prostaglandin E1: results and perspectives in clinical practice

Pralong, E..; Vesin, M.-F..; Droz, B.., 1990:
Prostaglandin E2 Receptors in the Chicken Spinal Cord: 1. Biochemical Characterization

Pralong, E..; Vesin, M.-F..; Droz, B.., 1990:
Prostaglandin E2 Receptors in the Chicken Spinal Cord: 2. Radioautographic Localization

Cila, E.; Alpaslan, A.M.; Melli, M.; Tokgözoğlu, A.M., 1994:
Prostaglandin E2 activity in the synovial-like membrane

Csukas, S.; Bhattacherjee, P.; Rhodes, L.; Paterson, C.A., 1993:
Prostaglandin E2 and F2 alpha binding sites in the bovine iris ciliary body

Miyoshi, T.; Suzuki, H.; Fujimoto, N.; Shio, H., 1995:
Prostaglandin E2 and its metabolites

Bode, C.; Maute, G.; Bode, J.C., 1996:
Prostaglandin E2 and prostaglandin F2 alpha biosynthesis in human gastric mucosa: effect of chronic alcohol misuse

Gobbetti, A.; Zerani, M. , 1993:
Prostaglandin E2 and prostaglandin F2 alpha involvement in the corticosterone and cortisol release by the female frog, Rana esculenta, during ovulation

Waterhouse, P.J.; Nunn, J.H.; Whitworth, J.M., 2002:
Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures

Casibang, M.; Purdom, S.; Jakowlew, S.; Neckers, L.; Zia, F.; Ben-Av, P.; Hla, T.; You, L.; Jablons, D.M.; Moody, T.W., 2001:
Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

ElAttar, T.M.; Lin, H.S., 1993:
Prostaglandin E2 antagonizes gingival fibroblast proliferation stimulated by interleukin-1 beta

Kaur, K.; Harris, S.G.; Padilla, J.; Graf, B.A.; Phipps, R.P., 2000:
Prostaglandin E2 as a modulator of lymphocyte mediated inflammatory and humoral responses

Sergeeva, M.G.; Gonchar, M.V.; Mevkh, A.T.; Varfolomeyev, S.D., 1998:
Prostaglandin E2 biphasic control of lymphocyte proliferation: inhibition by picomolar concentrations

Preshaw, P.M.; Heasman, P.A., 2002:
Prostaglandin E2 concentrations in gingival crevicular fluid: observations in untreated chronic periodontitis

Minghetti, L.; Nicolini, A.; Polazzi, E.; Créminon, C.; Maclouf, J.; Levi, G., 1997:
Prostaglandin E2 downregulates inducible nitric oxide synthase expression in microglia by increasing cAMP levels

Petersen, K.U.; Macherey, H.J., 1993:
Prostaglandin E2 effects on duodenal electrical conductance

Abul, H.T.; Davidson, J.; Milton, A.S.; Rotondo, D., 1997:
Prostaglandin E2 enters the brain following stimulation of the acute phase immune response

Miller, A.M.; Lorkovic, M., 1993:
Prostaglandin E2 for cervical ripening

Warke, H.S.; Saraogi, R.M.; Sanjwalla, S.M., 2000:
Prostaglandin E2 gel In ripening of cervix in induction of labour

Patnaik, P.; Rout, G.C., 1995:
Prostaglandin E2 gel for cervical priming and induction of labour in unfavourable cervical state

Darroca, R.J.; Buttino, L.; Miller, J.; Khamis, H.J., 1996:
Prostaglandin E2 gel for cervical ripening in patients with an indication for delivery

Major-Godlewska, M.; Karcz, J., 2018:
An effect of the tubular baffles configuration in an agitated vessel with a high-speed impeller on the power consumption

Milchev, N.; Pehlivanov, B.; Paskaleva, V.; Velchev, G.; Gurova, A., 2000:
Prostaglandin E2 in preinduction cervical ripening in postdate pregnancy

Alstergren, P.; Kopp, S., 2000:
Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders

Coceani, F.; Akarsu, E.S., 1999:
Prostaglandin E2 in the pathogenesis of fever. An update

Kanematsu, M.; Sato, T.; Takai, H.; Watanabe, K.; Ikeda, K.; Yamada, Y., 2000:
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency

Erämaa, M.; Ritvos, O., 1996:
Prostaglandin E2 induces inhibin alpha- and beta A-subunit mRNA and secretion of dimeric inhibin A in cultured human granulosa-luteal cells

Kaliński, P.; Schuitemaker, J.H.; Hilkens, C.M.; Kapsenberg, M.L., 1998:
Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation

Neisius, U.; Olsson, R.; Rukwied, R.; Lischetzki, G.; Schmelz, M., 2002:
Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls

Imoh-Ita, F.; Williams, S., 2003:
Prostaglandin E2 induction of labour proceeding to vaginal delivery after two previous caesarean sections

Watson, C.S.; Homan, J.H.; White, S.E.; Challis, J.R.; Bocking, A.D., 1999:
Prostaglandin E2 inhibition of fetal breathing movements is not sustained during prolonged reduced uterine blood flow in sheep

Raisz, L.G.; Fall, P.M.; Petersen, D.N.; Lichtler, A.; Kream, B.E., 1993:
Prostaglandin E2 inhibits alpha 1(I)procollagen gene transcription and promoter activity in the immortalized rat osteoblastic clonal cell line Py1a

Goncharevskaia, O.A.; Natochin, I.V., 1994:
Prostaglandin E2 inhibits resorption of magnesium ions in the newt kidney distal tubule

Suzuki, A.; Kotoyori, J.; Oiso, Y.; Kozawa, O., 1993:
Prostaglandin E2 is a potential mediator of extracellular ATP action in osteoblast-like cells

Tsai, C.F.; Lii, C.K.; Yang, J.J.; Liu, K.; Lin, W.L.; Chen, H.W., 2002:
Prostaglandin E2 is involved in the increase of cytochrome P-450 2B1 expression by alpha-tocopheryl succinate in primary rat hepatocytes in the presence of phenobarbital

Zhou, J.; Zou, S.; Zhao, W.; Zhao, Y., 1994:
Prostaglandin E2 level in gingival crevicular fluid and its relation to the periodontal pocket depth in patients with periodontitis

Oka, M.; Inaba, A.; Uchiyama, T.; Hazama, S.; Shimoda, K.; Suzuki, M.; Suzuki, T., 1994:
Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers

Leibur, E.; Tuhkanen, A.; Pintson, U.; Söder, P.O., 1999:
Prostaglandin E2 levels in blood plasma and in crevicular fluid of advanced periodontitis patients before and after surgical therapy

Zhou, J.; Zou, S.; Zhao, Y., 1994:
Prostaglandin E2 levels in gingival crevicular fluid and its relation to the depth of periodontal pocket in patients with periodontitis

Kökoğlu, E.; Tüter, Y.; Sandikçi, K.S.; Yazici, Z.; Ulakoğlu, E.Z.; Sönmez, H.; Ozyurt, E., 1999:
Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors

Brown, D.M.; Phipps, R.P., 1997:
Prostaglandin E2 mediated apoptosis in subsets of malignant B lymphoma cells

Sato, T.; Morita, I.; Murota, S., 1997:
Prostaglandin E2 mediates parathyroid hormone induced osteoclast formation by cyclic AMP independent mechanism

Czuszak, C.A.; Sutherland, D.E.; Billman, M.A.; Stein, S.H., 1996:
Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts

Witter, F.R., 2000:
Prostaglandin E2 preparations for preinduction cervical ripening

Ishihara, O.; Numari, H.; Saitoh, M.; Arai, Y.; Takanashi, H.; Kitagawa, H.; Kinoshita, K., 1997:
Prostaglandin E2 production by endogenous secretion of interleukin-1 in decidual cells from term fetal membrane

Inokuma, H.; Kemp, D.H.; Willadsen, P., 1994:
Prostaglandin E2 production by the cattle tick (Boophilus microplus) into feeding sites and its effect on the response of bovine mononuclear cells to mitogen

Dormond, O.; Bezzi, M.; Mariotti, A.; Ruegg, C., 2002:
Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling

Noguchi, K.; Iwasaki, K.; Shitashige, M.; Ishikawa, I., 2000:
Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts

McCord, M.; Bolognese, B.; Marshall, L.A., 1995:
Prostaglandin E2 requirement for transforming growth factor beta 1 inhibition of elicited macrophage 14 kDa phospholipase A2 release

Yagami, T.; Nakazato, H.; Ueda, K.; Asakura, K.; Kuroda, T.; Hata, S.; Sakaeda, T.; Sakaguchi, G.; Itoh, N.; Hashimoto, Y.; Hiroshige, T.; Kambayashi, Y., 2002:
Prostaglandin E2 rescues cortical neurons from amyloid beta protein-induced apoptosis

Gomi, K.; Zhu, F.G.; Marshall, J.S., 2000:
Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism

Mochiki, E.; Nakabayashi, T.; Suzuki, H.; Haga, N.; Asao, T.; Kuwano, H.; Itoh, Z., 2000:
Prostaglandin E2 stimulates motilin release via a cholinergic muscarinic pathway in the dog

Amano, S.; Naganuma, K.; Kawata, Y.; Kawakami, K.; Kitano, S.; Hanazawa, S., 1996:
Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A

Joshi, P.C.; Zhou, X.; Cuchens, M.; Jones, Q., 2001:
Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain

Tsai, C.Y.; Yu, C.L.; Hsieh, S.C.; Liao, T.S.; Lin, W.M., 1995:
Prostaglandin E2 suppresses the expression and release of beta 2-microglobulin from mitogen-activated normal human mononuclear cells

Nakatani, Y.; Kudo, I., 2003:
Prostaglandin E2 synthases

Abou el-Leil, L.A.; Nasrat, A.A.; Fayed, H.M., 1993:
Prostaglandin E2 vaginal pessaries in the grandmultipara with an unripe cervix, a comparison of different parity groups

Bowers, W.; Blaha, M.; Sankovich, J.; Patterson, D.; Dubose, D., 1993:
Prostaglandin E2, interleukin-1 alpha, and potassium release from artificial human skin after freeze-thaw injury

Wijayagunawardane, M.P.; Miyamoto, A.; Sato, K., 2000:
Prostaglandin E2, prostaglandin F2 alpha and endothelin-1 production by cow oviductal epithelial cell monolayers: effect of progesterone, estradiol 17 beta, oxytocin and luteinizing hormone

Bozhinova, S.; Porozhanova, V.; Popovski, K.; Bozhinov, P.; Atanasova, S., 1995:
Prostaglandin E2--an effective alternative for the induction of labor

Gil, L.; Han, Y.; Opas, E.E.; Rodan, G.A.; Ruel, R.; Seedor, J.G.; Tyler, P.C.; Young, R.N., 1999:
Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis

Ito, Y.; Takagi, K.; Tomita, T., 1995:
Prostaglandin E2-induced contraction and membrane potential change in bronchial smooth muscle

Fitzgerald, J.; Dietz, T.J.; Hughes-Fulford, M.; Hughes-Fulford, M., 1999:
Prostaglandin E2-induced up-regulation of c-fos messenger ribonucleic acid is primarily mediated by 3',5'-cyclic adenosine monophosphate in MC3T3-E1 osteoblasts

Pelzar, E.M., 1993:
Prostaglandin E2. Its role in preinduction cervical ripening, and its clinical use in obstetrics today. Introduction

Negishi, M., 1994:
Prostaglandin E2: molecular mechanisms for its diverse actions

Watanabe, K., 2002:
Prostaglandin F synthase

Helmersson, J.; Mattsson, P.; Basu, S., 2001:
Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine

Yoshida, M.; Sagawa, N.; Itoh, H.; Yura, S.; Takemura, M.; Wada, Y.; Sato, T.; Ito, A.; Fujii, S., 2002:
Prostaglandin F(2alpha), cytokines and cyclic mechanical stretch augment matrix metalloproteinase-1 secretion from cultured human uterine cervical fibroblast cells

Jimenez de Asua, L.; Goin, M., 1997:
Prostaglandin F2 alpha (PGF2 alpha) triggers protein kinase C (PKC) and tyrosine kinase activity in cultured mammalian cells

Kozawa, O.; Suzuki, A.; Kotoyori, J.; Tokuda, H.; Watanabe, Y.; Ito, Y.; Oiso, Y., 1994:
Prostaglandin F2 alpha activates phospholipase D independently from activation of protein kinase C in osteoblast-like cells

Abayasekara, D.R.; Jones, P.M.; Persaud, S.J.; Michael, A.E.; Flint, A.P., 1993:
Prostaglandin F2 alpha activates protein kinase C in human ovarian cells

Athari, A.; Hänecke, K.; Jungermann, K., 1994:
Prostaglandin F2 alpha and D2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine

Bland, K.P.; Poyser, N.L., 1995:
Prostaglandin F2 alpha and E2 production into uterine lymph of pregnant and non-pregnant ewes

Yousufzai, S.Y.; Ye, Z.; Abdel-Latif, A.A., 1996:
Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species

Fujimoto, N.; Shio, H.; Miyoshi, T.; Suzuki, H., 1995:
Prostaglandin F2 alpha and its metabolites

Bekana, M., 1997:
Prostaglandin F2 alpha and progesterone profiles in post-partum cows with short luteal phases

Conconi, M.T.; Spinazzi, R.; Tommasini, M.; Limoli, A.; Parnigotto, P.P., 2002:
Prostaglandin F2 alpha can modulate the growth and the differentiation of bovine corneal epithelial cells cultured in vitro

Watanabe, T.; Nakao, A.; Emerling, D.; Hashimoto, Y.; Tsukamoto, K.; Horie, Y.; Kinoshita, M.; Kurokawa, K., 1994:
Prostaglandin F2 alpha enhances tyrosine phosphorylation and DNA synthesis through phospholipase C-coupled receptor via Ca(2+)-dependent intracellular pathway in NIH-3T3 cells

Saito, H.; Yamamoto, T.; Kimura, M.; Shimokata, K., 1993:
Prostaglandin F2 alpha in the treatment of vinca alkaloid-induced ileus

Lai, J.; Jin, H.; Yang, R.; Winer, J.; Li, W.; Yen, R.; King, K.L.; Zeigler, F.; Ko, A.; Cheng, J.; Bunting, S.; Paoni, N.F., 1996:
Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo

Rayner, T.E.; Chen, B.N.; McLoughlin, J.W.; Menadue, M.F.; Norman, R.J.; Oliver, J.R., 1993:
Prostaglandin F2 alpha mediates platelet-activating factor-stimulated atrial natriuretic factor release from the isolated rat heart

Bekana, M.; Odensvik, K.; Kindahl, H., 1996:
Prostaglandin F2 alpha metabolite and progesterone profiles in post-partum cows with retained foetal membranes

Miyamoto, A.; Kobayashi, S.; Arata, S.; Ohtani, M.; Fukui, Y.; Schams, D., 1997:
Prostaglandin F2 alpha promotes the inhibitory action of endothelin-1 on the bovine luteal function in vitro

Sakamoto, K.; Kamimura, M.; Kurozumi, S.; Ito, S., 1995:
Prostaglandin F2 alpha receptor

Ito, S.; Sakamoto, K.; Mochizuki-Oda, N.; Ezashi, T.; Miwa, K.; Okuda-Ashitaka, E.; Shevchenko, V.I.; Kiso, Y.; Hayaishi, O., 1994:
Prostaglandin F2 alpha receptor is coupled to Gq in cDNA-transfected Chinese hamster ovary cells

Anthony, T.L.; Pierce, K.L.; Stamer, W.D.; Regan, J.W., 1998:
Prostaglandin F2 alpha receptors in the human trabecular meshwork

Wegner, J.A.; Martinez-Zaguilan, R.; Gillies, R.J.; Hoyer, P.B., 1994:
Prostaglandin F2 alpha releases calcium from a thapsigargin-sensitive pool in ovine large luteal cells

Liu, D.; Li, L., 1995:
Prostaglandin F2 alpha rises in response to hydroxyl radical generated in vivo

Adams, J.W.; Migita, D.S.; Yu, M.K.; Young, R.; Hellickson, M.S.; Castro-Vargas, F.E.; Domingo, J.D.; Lee, P.H.; Bui, J.S.; Henderson, S.A., 1996:
Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes

Maka, F.D.; Breuiller-Fouche, M.; Geny, B.; Ferre, F., 1993:
Prostaglandin F2 alpha stimulates inositol phosphate production in human pregnant myometrium

Gadsby, J.E.; Earnest, K.L., 1994:
Prostaglandin F2 alpha stimulates progesterone secretion by porcine luteal cells in vitro throughout the estrous cycle

Separovic, D.; Dorman, R.V., 1993:
Prostaglandin F2 alpha synthesis in the hippocampal mossy fiber synaptosomal preparation: I. Dependence in arachidonic acid, phospholipase A2, calcium availability and membrane depolarization

Noguchi, K.; Iwasaki, K.; Ishikawa, I., 1999:
Prostaglandin F2 alpha upregulates intercellular adhesion molecule-1 expression in human gingival fibroblasts

Del Vecchio, R.P.; Sutherland, W.D.; Sasser, R.G., 1995:
Prostaglandin F2 alpha, progesterone and oxytocin production by cultured bovine luteal cells treated with prostaglandin E2 and pregnancy-specific protein B

Quarles, L.D.; Haupt, D.M.; Davidai, G.; Middleton, J.P., 1993:
Prostaglandin F2 alpha-induced mitogenesis in MC3T3-E1 osteoblasts: role of protein kinase-C-mediated tyrosine phosphorylation

Sugiyama, T.; Sakai, T.; Nozawa, Y.; Oka, N., 1994:
Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production

Kunapuli, P.; Lawson, J.A.; Rokach, J.A.; Meinkoth, J.L.; FitzGerald, G.A., 1998:
Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways

Salli, U.; Stormshak, F., 2002:
Prostaglandin F2alpha-activated protein kinase Calpha phosphorylates myristoylated alanine-rich C kinase substrate protein in bovine luteal cells

Liu, J.; Carrière, P.D.; Doré, M.; Sirois, J., 1998:
Prostaglandin G/H synthase-2 is expressed in bovine preovulatory follicles after the endogenous surge of luteinizing hormone

Lim, K.M.; Lee, J.Y.; Kim, J.S.; Chung, J.H., 2000:
Prostaglandin H synthase and lipoxygenase mediated activation of xenobiotics in platelets

Stiborová, M.; Schmeiser, H.H.; Frei, E., 2000:
Prostaglandin H synthase-medicated oxidation and binding to DNA of a detoxication metabolite of carcinogenic Sudan I, 1-(phenylazo)-2,6-dihydroxynaphthalene

Mevkh, A.T.; Miroshnikov, K.A.; Igumnova, N.D.; Varfolomeev, S.D., 1993:
Prostaglandin H synthase. Chemical modification of histidine residues in various forms of the enzyme by diethylpyrocarbonate

Vogel, C., 2001:
Prostaglandin H synthases and their importance in chemical toxicity

Somova, L., 1996:
Prostaglandin H2/thromboxane A2 pathway in platelet aggregation and activity of Dahl salt-sensitive rat--a sulotroban study

Reilly, C.M.; Oates, J.C.; Sudian, J.; Crosby, M.B.; Halushka, P.V.; Gilkeson, G.S., 2001:
Prostaglandin J(2) inhibition of mesangial cell iNOS expression

Evers, S.; Masur, H.; Sörös, P.; Brilla, R.; Husstedt, I.W., 2001:
Prostaglandin analog mechanisms are not effective in refractory chronic cluster headache

Hejkal, T.W.; Camras, C.B., 2000:
Prostaglandin analogs in the treatment of glaucoma

Gallucci, G.M., 1996:
Prostaglandin analogues: a new classification of ocular hypotensive agents used in the treatment of glaucoma

Yoshida, H.; Ura, N.; Shimamoto, K., 1997:
Prostaglandin and kallikrein-kinin systems

Bobadilla Lugo, R.A.; Hernández Hernández, D.; Castillo Henkel, C.; Hong, E., 1998:
Prostaglandin and nitric oxide interactions in rat aorta

Achari, K.; Singh, G., 1979:
Prostaglandin and the corpus luteum of pregnancy

Fan, H.Y.; Yang, Z.M., 2003:
Prostaglandin and their receptors in mammalian reproduction

Linz, D.N.; Garcia, V.F.; Arya, G.; Ziegler, M.M., 1994:
Prostaglandin and tumor necrosis factor levels in early wound inflammatory fluid: effects of parenteral omega-3 and omega-6 fatty acid administration

Crofford, L.J., 2002:
Prostaglandin biology

Wallace, J.L., 2002:
Prostaglandin biology in inflammatory bowel disease

Pedibhotla, V.K.; Sarath, G.; Sauer, J.R.; Stanley-Samuelson, D.W., 1995:
Prostaglandin biosynthesis and subcellular localization of prostaglandin H synthase activity in the lone star tick, Amblyomma americanum

Stanley-Samuelson, D.W.; Ogg, C.L., 1994:
Prostaglandin biosynthesis by fat body from the tobacco hornworm, Manduca sexta

Mitsuhashi, N.; Kuwabara, Y., 1994:
Prostaglandin biosynthesis in the umbilical artery and its relation to fetal growth

Morozova, M.S.; Goncharova, V.N.; Astakhova, T.M.; Zaĭtseva, T.S.; Manuilova, I.A., 1994:
Prostaglandin content in decidual tissue of women in spontaneous abortion

Kmiec, Z., 1994:
Prostaglandin cytoprotection of galactosamine-incubated hepatocytes isolated from young and old rats

Alm, A., 1998:
Prostaglandin derivates as ocular hypotensive agents

Arakawa, T.; Higuchi, K.; Fujiwara, Y.; Watanabe, T.; Tominaga, K., 2002:
Prostaglandin derivatives--indication and critical points

Rabinowitz, B.; Schollmayer, E.; Weiss, M., 1999:
Prostaglandin e1 in heart disease: review and perspective

Teixeira, F.J.; Zakar, T.; Hirst, J.; Guo, F.; Machin, G.; Olson, D.M., 1993:
Prostaglandin endoperoxide H synthase (PGHS) activity increases with gestation and labour in human amnion

Mijovic, J.E.; Demianczuk, N.; Olson, D.M.; Zakar, T., 2000:
Prostaglandin endoperoxide H synthase mRNA expression in the fetal membranes correlates with fetal fibronectin concentration in the cervico-vaginal fluids at term: evidence of enzyme induction before the onset of labour

Mijovic, J.E.; Zakar, T.; Angelova, J.; Olson, D.M., 1999:
Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour

Hirst, J.J.; Mijovic, J.E.; Zakar, T.; Olson, D.M., 1998:
Prostaglandin endoperoxide H synthase-1 and -2 mRNA levels and enzyme activity in human decidua at term labor

Zakar, T.; Mijovic, J.E.; Olson, D.M., 1997:
Prostaglandin endoperoxide H synthase-2 expression in human amnion cells: involvement of tyrosine kinases in the regulation

Smith, W.L.; Dewitt, D.L., 1996:
Prostaglandin endoperoxide H synthases-1 and -2

Tong, H.; Richards, E.; Wood, C.E., 1999:
Prostaglandin endoperoxide synthase-2 abundance is increased in brain tissues of late-gestation fetal sheep in response to cerebral hypoperfusion

Teixeira, F.J.; Zakar, T.; Hirst, J.J.; Guo, F.; Sadowsky, D.W.; Machin, G.; Demianczuk, N.; Resch, B.; Olson, D.M., 1994:
Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor

Gafencu, O.; Cârstocea, B.; Ioniţă, M., 2000:
Prostaglandin esters--new directions in the treatment of glaucoma

Tammela, T., 2001:
Prostaglandin in the treatment of impotence

Krishnan, K.; Brenner, D.E., 2002:
Prostaglandin inhibitors and the chemoprevention of noncolonic malignancy

Heeg, M.M., 1995:
Prostaglandin injection therapy for men with a reasonable level of sexual activity

Silva, P.J.; Juengel, J.L.; Rollyson, M.K.; Niswender, G.D., 2000:
Prostaglandin metabolism in the ovine corpus luteum: catabolism of prostaglandin F(2alpha) (PGF(2alpha)) coincides with resistance of the corpus luteum to PGF(2alpha)

Schoenfeld, A.; Warchaizer, S.; Erman, A.; Hod, M., 1996:
Prostaglandin metabolism in the yolk sacs of normal and diabetic pregnancies

Lang, C.C.; Chomsky, D.B.; Butler, J.; Kapoor, S.; Wilson, J.R., 1998:
Prostaglandin production contributes to exercise-induced vasodilation in heart failure

Jones, R.L.; Armstrong, R.A.; Wise, H., 1997:
Prostaglandin receptors involved in inflammatory events

Fedyk, E.R.; Harris, S.G.; Padilla, J.; Phipps, R.P., 1997:
Prostaglandin receptors of the EP2 and EP4 subtypes regulate B lymphocyte activation and differentiation to IgE-secreting cells

Breyer, M.D.; Breyer, R.M., 2000:
Prostaglandin receptors: their role in regulating renal function

Hughes-Fulford, M.; Hughes-Fulford, M., 1997:
Prostaglandin regulation of gene expression and growth in normal and malignant tissues

Collins, P.; Jung, C.J.; Pappo, R., 1968:
Prostaglandin studies: the total synthesis of DL-prostaglandin B1

Takewa, Y.; Seki, T.; Tatsumi, E.; Taenaka, Y.; Takano, H., 2001:
Prostaglandin synthesis inhibitor improves hypotension during normothermic cardiopulmonary bypass

Sato, K.; Takewa, Y.; Taenaka, Y.; Tatsumi, E.; Nishinaka, T.; Shioya, K.; Fukuda, T.; Ohnishi, H.; Oshikawa, M.; Uesho, K.; Takano, H.; Hayashi, J-ichi., 2002:
Prostaglandin synthesis inhibitor prevents hypotension without impairing gut perfusion during normothermic cardiopulmonary bypass

Tokyay, R.; Kaya, E.; Gur, E.S.; Tuncel, P.; Ozbek, R.; Ozturk, E., 1999:
Prostaglandin synthetase inhibition reduces peritonitis-induced early liver oxidant stress

Van den Veyver, I.B.; Moise, K.J., 1993:
Prostaglandin synthetase inhibitors in pregnancy

Matsumura, K.; Cao, C.; Watanabe, Y.; Watanabe, Y., 1998:
Prostaglandin system in the brain: sites of biosynthesis and sites of action under normal and hyperthermic states

Kruse, H.J.; Schellong, S., 2001:
Prostaglandin therapy in arterial occlusive disease

Linhart, J., 2000:
Prostaglandin therapy of peripheral occlusive arterial disease

Conejero Sugrañes, J.; Muñoz Villellas, A.; Sarrias Lorenz, Fán.; Ramírez Garceran, L., 2002:
Prostaglandin treatment in neurological patients with erectile dysfunction

Lodge, N., 2000:
Prostaglandin use in sows

Sack, S., 1999:
Prostaglandin--a pluralistic hormone embracing divergent signal properties

Dutta-Roy, A.K.; Hoque, L.; Paterson, B.J., 1993:
Prostaglandin-E1-binding sites in rabbit erythrocyte membranes

Wintergalen, N.; Thole, H.H.; Galla, H.J.; Schlegel, W., 1995:
Prostaglandin-E2 9-reductase from corpus luteum of pseudopregnant rabbit is a member of the aldo-keto reductase superfamily featuring 20 alpha-hydroxysteroid dehydrogenase activity

Beĭsembaeva, R.U.; Zatserkovnaia, T.A.; Kuznetsova, I.A.; Mevkh, A.T., 1999:
Prostaglandin-H-synthase: stability and activity during immobilization on silica gel

Natochin YuV; Shakhmatova, E.I.; Komissarchik YaYu; Snigirevskaya, E.S.; Prutskova, N.P.; Brudnaya, M.S., 1999:
Prostaglandin-dependent osmotic water permeability of the frog and trout urinary bladder

Dagan, O.; Peled, N.; Babin, P.; Silver, M.; Barker, G.; Koren, G., 1993:
Prostaglandin-induced antral hyperplasia in neonates: clinical experience and dose-response characteristics

Harrington, K.J..; Lambert, H.E..; Kelly, S.A..; Lai, P.S..; Price, G.D.., 1994:
Prostaglandin-induced cervical dilatation prior to intracavitary radiotherapy for carcinoma of the cervix: a pilot study

Bieńkiewicz, A.; Kuś, E.; Welfel, J., 1996:
Prostaglandin-induced changes and the influence of cyclo-and lipoxygenase inhibitors on the uterine collagen concentration in late pregnancy in rats

Mercado-Deane, M.G.; Burton, E.M.; Brawley, A.V.; Hatley, R., 1994:
Prostaglandin-induced foveolar hyperplasia simulating pyloric stenosis in an infant with cyanotic heart disease

Vasko, M.R., 1995:
Prostaglandin-induced neuropeptide release from spinal cord

Hanson, W.R.; Collins, P.W., 1992:
Prostaglandin-induced radioprotection of murine intestinal crypts and villi by a PGE diene analog (SC-44932) and a PGI analog (iloprost)

Sammour, M., 1971:
Prostaglandins (PGS)

Mikriukova, V.I.; Beloborodova, E.I., 1996:
Prostaglandins E concentration in gastric mucosa and synthesis of interleukin-1 (IL-1) in different clinical variants of gastric ulcer

Kushlinskiĭ, N.E.; Podistov, I.I.; Laktionov, K.P.; Karseladze, A.I.; Babkina, I.V.; Kerimova, G.I., 1997:
Prostaglandins E in the primary tumor, metastases, and ascitic fluid of patients with ovarian cancer

Stepanov, I.M., 1999:
Prostaglandins E in tumor tissue from patients with stomach cancer

DiBattista, J.A.; Martel-Pelletier, J.; Fujimoto, N.; Obata, K.; Zafarullah, M.; Pelletier, J.P., 1994:
Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway

Noguchi, K.; Iwasaki, K.; Endo, H.; Kondo, H.; Shitashige, M.; Ishikawa, I., 2001:
Prostaglandins E2 and I2 downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human oral gingival epithelial cells

Separovic, D.; Dorman, R.V., 1993:
Prostaglandins F2 alpha synthesis in the hippocampal mossy fiber synaptosomal preparation: II. Effects of receptor activation

Caballero, A.; Garcia Albertos, F.; Corredera, J.; Alonso Magan, J.L., 1974:
Prostaglandins PGF2 alpha, E1, and F2 alpha and delivery induction by intravenous infusion

Hain, A.M., 1935:
An Effect on the Rat of Antenatal and Postnatal Administration of Œstrin

Sinzinger, H.; Rogatti, W., 1994:
Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies

Raisz, L.G., 1999:
Prostaglandins and bone: physiology and pathophysiology

Kaufman, P.L., 1997:
Prostaglandins and cholinomimetics

Iagoda, A.V.; Topchieva, G.Iu.; Geĭvandova, N.I.; Markova, I.V., 1993:
Prostaglandins and collagen metabolism in chronic liver diseases

Khan, M.A.; Thompson, C.S.; Angelini, G.D.; Morgan, R.J.; Mikhailidis, D.P.; Jeremy, J.Y., 2000:
Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction

Milton, A.S., 1998:
Prostaglandins and fever

Robert, A., 1973:
Prostaglandins and gastric secretion

Morteau, O., 2001:
Prostaglandins and inflammation: the cyclooxygenase controversy

Zhu, J.H., 1987:
Prostaglandins and intrauterine contraceptive device

Ming, S.H.; Jiang, L.; Qing, Z.T., 1994:
Prostaglandins and neonatal hypoxia diseases

Slater, D.M.; Zervou, S.; Thornton, S., 2002 :
Prostaglandins and prostanoid receptors in human pregnancy and parturition

Navarro, J.F., 1996:
Prostaglandins and renal damage

Laron, E.; Mazor, M.; Leiberman, J.R., 1998:
Prostaglandins and termination of second trimester pregnancy

Oegema, T.R..; Johnson, S.L..; Meglitsch, T.; Carpenter, R.J.., 1996:
Prostaglandins and the Zone of Calcified Cartilage in Osteoarthritis

Ferreira, S.H.; Moncada, S.; Vane, J.R.; Ferreira, S.H.; Moncada, S.; Vane, J.R., 1997:
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973

Rigas, B., 1995:
Prostaglandins and the pathophysiology of esophagitis

Filicky, J.; Florean, L.; Mikulaj, V., 1972:
Prostaglandins and the reproductive cycle

Lukacin, S., 1972:
Prostaglandins and their importance in obstetrics

Miyazaki, Y.; Toki, Y., 2000:
Prostaglandins and their related substances

Rodrigues, M.; Havlik, E.; Peskar, B.; Sinzinger, H., 1998:
Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?

Morgan, G.P.; Williams, J.G., 1993:
Prostaglandins as mediators of lower esophageal sphincter dysfunction in esophagitis

Okawa, T.; Suzuki, Y.; Hoshi, K.; Endo, C.; Sato, A.; Nakanishi, H., 1993:
Prostaglandins biosynthesis in the rabbit uterine cervix at various stages of pregnancy

Miller, V.M.; Vanhoutte, P.M., 2001:
Prostaglandins but not nitric oxide are endothelium-derived relaxing factors in the trout aorta

Reznichenko, I.G.; Reznichenko, G.I.; Ventskovskyĭ, B.M., 1993:
Prostaglandins content in the blood of newborns with various types of hypoxia

Lee, W.M., 1996:
Prostaglandins for clinical use: are we there yet?

Anonymous, 1971:
Prostaglandins for induced abortion. The uteral muscle is directly stimulated into contracting

Tan, B.P.; Hannah, M.E., 2000:
Prostaglandins for prelabour rupture of membranes at or near term

Clewell, J.D.; Walker-Renard, P., 1994:
Prostaglandins for the treatment of hepatorenal syndrome

Anonymous, 1972:
Prostaglandins form faster after a burn

Loginov, A.S.; Vysotskaia, R.A., 1995:
Prostaglandins in chronic liver diseases

Pustisek, N.; Lipozencić, J., 2002:
Prostaglandins in dermatology

Iberer, F.; Wasler, A.; Petutschnigg, B.; Müller, H.; Allmayer, T.; Grasser, B.; Prenner, G.; Schaffellner, S.; Hipmayr, G.; Tscheliessnigg, K.H., 1997:
Prostaglandins in heart transplantation

Peltekian, K.M.; Makowka, L.; Williams, R.; Blendis, L.M.; Levy, G.A., 1996:
Prostaglandins in liver failure and transplantation: regeneration, immunomodulation, and cytoprotection. Prostaglandins in Liver Transplantation Research Group

Henley, K.S.; Smith, D., 1997:
Prostaglandins in liver transplantation: a $50,000 bonus

Schafer, D.F.; Sorrell, M.F., 1996:
Prostaglandins in liver transplantation: a promise unfulfilled

Booke, M.; Van Aken, H.; Theilmeier, G.; Meyer, J., 1998:
Prostaglandins in patients with pulmonary hypertension: the route of administration

Milasinović, L.; Vuleta, P.; Radeka, G.; Petrović, D.; Orelj, M., 1997:
Prostaglandins in the induction of labor at term with premature rupture of fetal membranes

Arakawa, T.; Higuchi, K.; Fukuda, T.; Fujiwara, Y.; Kobayashi, K.; Kuroki, T., 1999:
Prostaglandins in the stomach: an update

Molendijk, L.W., 1993:
Prostaglandins in the termination of mid-trimester pregnancy

Bojić, I.; Mijusković, P., 1993:
Prostaglandins in the treatment of serious forms of hepatitis

Zahradnik, H.P.; Möller, K.; Stumme, H.; Casper, F.W.; Seufert, R.; Schäfer, W., 1994:
Prostaglandins in the urine of hypertensive pregnant patients

Weinreb, R.N.; Kashiwagi, K.; Kashiwagi, F.; Tsukahara, S.; Lindsey, J.D., 1998:
Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells

Lindsey, J.D.; Kashiwagi, K.; Boyle, D.; Kashiwagi, F.; Firestein, G.S.; Weinreb, R.N., 1996:
Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells

Shimizu, Y.; Yorimitsu, A.; Maruyama, Y.; Kubota, T.; Aso, T.; Bronson, R.A., 1998:
Prostaglandins induce calcium influx in human spermatozoa

Harizi, H.; Juzan, M.; Moreau, J-François.; Gualde, N., 2002:
Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism

Sjöholm, A., 1996:
Prostaglandins inhibit pancreatic beta-cell replication and long-term insulin secretion by pertussis toxin-insensitive mechanisms but do not mediate the actions of interleukin-1 beta

Leung, F.W., 1994:
Prostaglandins mediate fish oil protection against ethanol-induced gastric mucosal injury in rats

Batzer, R.; Liu, Y.; Cochran, D.L.; Szmuckler-Moncler, S.; Dean, D.D.; Boyan, B.D.; Schwartz, Z., 1998:
Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1 alpha,25-(OH)2D3

Sharma, H.S.; Westman, J., 1997:
Prostaglandins modulate constitutive isoform of heat shock protein (72 kD) response following trauma to the rat spinal cord

Geraldo, J.; Ferraz, P.; Wallace, J.L., 1996:
Prostaglandins modulate the responsiveness of the gastric microcirculation of sodium nitroprusside in cirrhotic rats

Samuelsson, B., 1963:
Prostaglandins of human seminal plasma

Kushlinskiĭ, N.E.; Solov'ev, I.N., 1995:
Prostaglandins of series E in morphologic variants of osteogenic sarcoma and evaluation of the degree of therapeutic pathomorphism of the tumor

Malkinson, F.D.; Geng, L.; Hanson, W.R., 1993:
Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin

McCray, P.B.; Bettencourt, J.D., 1993:
Prostaglandins stimulate fluid secretion in human fetal lung

Ito, H.; Okamoto, K.; Kato, K., 1997:
Prostaglandins stimulate the stress-induced synthesis of hsp27 and alpha B crystallin

Anonymous, 1967:
Prostaglandins synthesized at McGill

Tan, B.P.; Hannah, M.E., 2000:
Prostaglandins versus oxytocin for prelabour rupture of membranes at or near term

Tan, B.P.; Hannah, M.E., 2000:
Prostaglandins versus oxytocin for prelabour rupture of membranes at term

Dajani, E.Z., 1996:
Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?

Uotila, P., 1993:
Prostaglandins, histamine and cancer immunotherapy

Cook, J.A.; Geisel, J.; Halushka, P.V.; Reines, H.D., 1993:
Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid

Hayaishi, O., 1994:
Prostaglandins--present and future

Legeza, V.I.; Shagoian, M.G.; Chigareva, N.G.; Kamynina, M.F.; Turlakov, I.S., 1994:
Prostaglandins--their role in the mechanisms of the development of the primary reaction to radiation syndrome

Ristimäki, A.; Viinikka, L., 1996:
Prostaglandins. What is new?

Lemnete, I.; Sita, S.; Peltecu, G.; Radulescu, M., 1987:
Prostaglandins: a factor triggering labor and fetal expulsion in the second trimester

Shaw, J.E.; Ramwell, P.W., 1971:
Prostaglandins: a general review

Corbett, J.V.; Akin, V., 1994:
Prostaglandins: a variety of uses for clinical practice

Hagenfeldt, K., 1980:
Prostaglandins: mechanism of action and side effects of intrauterine devices

Raisz, L.G.; Pilbeam, C.C.; Fall, P.M., 1993:
Prostaglandins: mechanisms of action and regulation of production in bone

Portoghese, P.S., 1972:
Prostaglandins: the once-a-month birth control pill of the future

Janusz, A.G.; Janusz, A.J., 1993:
Prostaglandins: viable therapy in gastric ulceration

Liong, M.L.; Suzuki, T.; Yamanaka, H.; Kurokawa, K.; Daikuzono, N.; Nakazato, M., 1994:
Prostalase: basic clinical research and preliminary clinical results with laser thermotherapy for symptomatic benign prostatic hyperplasia

Razumov, S.V.; Derevianko, I.I.; Sivkov, A.V., 2001:
Prostamol-uno in the treatment of benign prostatic hyperplasia

Suchkova, V., 1997:
Prostanoid and anti-thrombin III levels in premature infants

Dormandy, J.A., 1996:
Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience

Kamphuis, W.; Schneemann, A.; van Beek, L.M.; Smit, A.B.; Hoyng, P.F.; Koya, E., 2001:
Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach

Narumiya, S., 1996:
Prostanoid receptors and signal transduction

Kimblad, P.O.; Gréen, K.; Sjöberg, T.; Steen, S., 1996:
Prostanoid release after lung transplantation

Peredo, H.A., 2002:
Prostanoid release and constrictor responses to noradrenaline in the rat mesenteric vascular bed in non-insulin-dependent diabetes mellitus

Brückner, U.B.; Rösch, M.; Kelbel, M.W.; Gebhard, F., 1999:
Prostanoid release and lipid peroxidation in patients with thoracic trauma

Keelan, J.A.; Sato, T.A.; Gupta, D.K.; Marvin, K.W.; Mitchell, M.D., 2000:
Prostanoid stimulation of cytokine production in an amnion-derived cell line: evidence of a feed-forward mechanism with implications for term and preterm labor

Shimonishi, M.; Tanabe, T., 1999:
Prostanoid synthases

Kis, B.; Mezei, Z.; Forgács, P.; Gecse, A.; Telegdy, G.; Bari, F., 2002:
Prostanoid synthesis in the cerebral blood vessels of asphyxiated piglets

Birrell, G.J.; McQueen, D.S.; Iggo, A.; Grubb, B.D., 1993:
Prostanoid-induced potentiation of the excitatory and sensitizing effects of bradykinin on articular mechanonociceptors in the rat ankle joint

Duffy, S.J.; Meredith, I.T., 2002:
Prostanoids do not affect endothelium-dependent vasodilation in healthy humans

Anonymous, 1999:
Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori

Reiter, M.; Bucek, R.A.; Stümpflen, A.; Dirisamer, A.; Minar, E., 2003:
Prostanoids in the treatment of intermittent claudication--a meta-analysis

Flisiak, R., 1998:
Prostanoids in treatment of liver diseases

Medvedev, A.A.; Siniakova, L.A.; Zaĭtsev, A.V., 2001:
Prostaplant treatment of benign prostatic hyperplasia

Wang, J.; Lundqvist, M.; Carlsson, L.; Nilsson, O.; Lundkvist, O.; Ronquist, G., 2001:
Prostasome-like granules from the PC-3 prostate cancer cell line increase the motility of washed human spermatozoa and adhere to the sperm

Ronquist, G.; Nilsson, B.O., 1998:
Prostasomes enhance sperm capacity. Prostatic components, or antibodies against them, may be used in in vitro fertilization, as contraceptive agents and for the diagnosis of cancer

Saez, F.; Motta, C.; Boucher, D.; Grizard, G., 2000:
Prostasomes inhibit the NADPH oxidase activity of human neutrophils

Honn, K.V.; Aref, A.; Chen, Y.Q.; Cher, M.L.; Crissman, J.D.; Forman, J.D.; Gao, X.; Grignon, D.; Hussain, M.; Porter, A.T.; Pontes, E.J.; Powell, I.; Redman, B.; Sakr, W.; Severson, R.; Tang, D.G.; Wood, D.P., 1996:
Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects)

Crawford, E.D., 1997:
Prostate Cancer Awareness Week: September 22 to 28, 1997

Honn, K.V.; Aref, A.; Chen, Y.Q.; Cher, M.L.; Crissman, J.D.; Forman, J.D.; Gao, X.; Grignon, D.; Hussain, M.; Porter, A.T.; Pontes, J.Edson.; Powell, I.; Redman, B.; Sakr, W.; Severson, R.; Tang, D.G.; Wood, D.P., 1996:
Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment

Reynolds, T., 1993:
Prostate Cancer Prevention Trial launched

Wright, K.D.; Oshima, T.C., 2015:
An Effect Size Measure for Raju's Differential Functioning for Items and Tests

Anonymous, 1998:
Prostate Cancer. Progress in screening, prevention holds promise

Ney, 1995 :
Prostate Cancer: A View From the Other Side of the Fence

Pow-Sang, 1995:
Prostate Cancer: Detection and Management

Pow-Sang, 2000:
Prostate Cancer: Of Turtles, Birds, and Rabbits

Matlaga, B.R.; Veys, J.A.; Thacker, C.C.; Assimos, D.G., 2001:
Prostate abscess following intravesical bacillus Calmette-Guerin treatment

Hill, V.E.; Brownstein, S.; Leonard, B.C.; Jordan, D.R., 1998:
Prostate adenocarcinoma presenting as a solitary choroidal metastasis

Yamazaki, T.; Suzuki, H.; Tobe, T.; Sekita, N.; Kito, H.; Ichikawa, T.; Akakura, K.; Igarashi, T.; Ito, H., 2001:
Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone

Mora, L.B.; Buettner, R.; Ahmad, N.; Bassel, Y.; Jove, R.; Seigne, J.D., 2002:
Prostate adenocarcinoma: cellular and molecular abnormalities

Navratil, H., 1998:
Prostate adenoma. Diagnosis, evolution, treatment

Goldstein, M.M.; Messing, E.M., 1998:
Prostate and bladder cancer screening

Chan, S.L.; Tammariello, S.P.; Estus, S.; Mattson, M.P., 1999:
Prostate apoptosis response-4 mediates trophic factor withdrawal-induced apoptosis of hippocampal neurons: actions prior to mitochondrial dysfunction and caspase activation

Wasson, J.H.; Bubolz, T.A.; Yao, G.Lu.; Barry, M.J., 2002 :
Prostate biopsies in men with limited life expectancy

Shaw, E.B.; Daniel, B.W.; Wofford, E.D.; Carter, J.B., 1996:
Prostate biopsies: optimized cancer detection and staging

Iczkowski, K.A.; Bostwick, D.G., 2000:
Prostate biopsy 1999: strategies and significance of pathological findings

Lee, J.C.; Muller, C.H.; Rothman, I.; Agnew, K.J.; Eschenbach, D.; Ciol, M.A.; Turner, J.A.; Berger, R.E., 2003:
Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls

King, C.R.; Long, J.P., 2001:
Prostate biopsy grading errors: a sampling problem?

Albertsen, P.; Fine, J., 1995:
Prostate biopsy in the community: who are the most likely candidates?

Zeng, J.; Bauer, J.; Zhang, W.; Sesterhenn, I.; Connelly, R.; Lynch, J.; Moul, J.; Mun, S.K., 2001:
Prostate biopsy protocols: 3D visualization-based evaluation and clinical correlation

Moul, J.W., 2002:
Prostate biopsy quantitative histology as a staging and prognostic factor

Zeng, J.; Bauer, J.; Zhang, W.; Sesterhenn, I.; Moul, J.; Mun, S.K., 1999:
Prostate biopsy schemes: 3-D visualization-based evaluation

Scherr, D.S.; Eastham, J.; Ohori, M.; Scardino, P.T., 2002:
Prostate biopsy techniques and indications: when, where, and how?

Carroll, P.R., 2000:
Prostate biopsy: a wealth of information when done and interpreted correctly

Introini, C.; Puppo, P., 2001:
Prostate biopsy: assessment of current indications and techniques

Matlaga, B.R.; Eskew, L.Andrew.; McCullough, D.L., 2002:
Prostate biopsy: indications and technique

Ladak, H.M.; Mao, F.; Wang, Y.; Downey, D.B.; Steinman, D.A.; Fenster, A., 2000:
Prostate boundary segmentation from 2D ultrasound images

Stone, N.N.; Stock, R.G., 2000:
Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality

Percarpio, B.; Sanchez, P.; Kraus, P.; Corujo, M.; D'Addario, P.; Wolk, J., 2000:
Prostate brachytherapy--the community hospital experience

Blasko, J.C.; Ragde, H.; Grimm, P.D.; Cavanagh, W., 1996:
Prostate brachytherapy: importance of technique

D'Amico, A.V.; Vogelzang, N.J., 1999:
Prostate brachytherapy: increasing demand for the procedure despite the lack of standardized quality assurance and long term outcome data

Chodak, G.W., 1997:
Prostate cancer

Moul, J.W., 1997:
Prostate cancer 1997--practicing what we preach

Cohen, S.P.; Jaskulsky, S.R., 2001:
Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences

Powell, I.J., 1997:
Prostate cancer and African-American men

Mameghan, H., 1999:
Prostate cancer and PSA screening

Komiya, A.; Ito, H., 2000:
Prostate cancer and androgen

Middleton, R.G., 1996:
Prostate cancer and aspects of radical prostatectomy

Brawley, O.W., 1998:
Prostate cancer and black men

Kylmälä, T., 1998:
Prostate cancer and bone metastases. The effect of clodronate

Denmark-Wahnefried, W., 1999:
Prostate cancer and diet

Collins, G.N.; O'Reilly, P.H.; Brooman, P.J.; Earnshaw, R.J.; Martin, P.J., 1998:
Prostate cancer and free PSA in routine laboratory use

Eton, D.T.; Lepore, S.J., 2002:
Prostate cancer and health-related quality of life: a review of the literature

Billington, A., 1999:
Prostate cancer and its effect on sexuality

Saksela, E., 1997:
Prostate cancer and medical ethics

Nixon, D.W., 2000:
Prostate cancer and nutrition

Gao, M.; Wang, J.; Song, X.; He, X.; Dahlgren, R.A.; Zhang, Z.; Ru, S.; Wang, X., 2018:
An effervescence-assisted switchable fatty acid-based microextraction with solidification of floating organic droplet for determination of fluoroquinolones and tetracyclines in seawater, sediment, and seafood

Thompson, I.M., 1994:
Prostate cancer and quality of life

Chen, T.C., 2001:
Prostate cancer and spinal cord compression

Uzzo, R.G.; Wei, J.T., 2002:
Prostate cancer and the educated consumer

Stark, N.; Paskett, E.; Demark-Wahnefried, W.; Carbone, E.; Godley, P., 2001:
Prostate cancer as a public health issue in North Carolina

Nakata, S.; Hasumi, M.; Sato, J.; Ogawa, A.; Yamanaka, H., 1998:
Prostate cancer associated with long-term intake of patent medicine containing methyltestosterone: a case report

Coard, K.C.M., 2002:
Prostate cancer at the University Hospital of the West Indies in Jamaica. A clinico-pathological profile at the time of needle biopsy diagnosis

Pow-Sang, J.M., 2002:
Prostate cancer at the beginning of the 21st century: more options and better outcomes

Cooper, C.R.; McLean, L.; Mucci, N.R.; Poncza, P.; Pienta, K.J., 2001:
Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by beta-1 integrin subunit

Hobisch, A.; Ramoner, R.; Fuchs, D.; Godoy-Tundidor, S.; Bartsch, G.; Klocker, H.; Culig, Z., 2001:
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype

Weissensteiner, T., 1998:
Prostate cancer cells show a nearly 100-fold increase in the expression of the longer of two alternatively spliced mRNAs of the prostate-specific membrane antigen (PSM)

Gupta, S.; Ahmad, N.; Mukhtar, H., 1999:
Prostate cancer chemoprevention by green tea

Crawford, E.D.; DeAntoni, E.P.; Hussain, M.; Thompson, I.M.; Coltman, C.A., 1997:
Prostate cancer clinical trials of the Southwest Oncology Group

Thompson, I., 2000:
Prostate cancer conundrum

Brawer, M.K., 1994:
Prostate cancer detection

Cooner, W.H.; Mosley, B.R.; Rutherford, C.L.; Beard, J.H.; Pond, H.S.; Terry, W.J.; Igel, T.C.; Kidd, D.D., 2002:
Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. 1990

Reiter, R.E., 1999:
Prostate cancer diagnostics--obstacles and opportunities

Weinrich, S.; Holdford, D.; Boyd, M.; Creanga, D.; Cover, K.; Johnson, A.; Frank-Stromborg, M.; Weinrich, M., 1998 :
Prostate cancer education in African American churches

Warrick, C.; Wutoh, A.K.; Corria-McDow, Z.; Emekalam, A., 2002:
Prostate cancer education in the Washington, DC, area

Bruner, D.W.; Pickett, M.; Joseph, A.; Burggraf, V., 2000:
Prostate cancer elder alert. Epidemiology, screening, and early detection

Pickett, M.; Bruner, D.W.; Joseph, A.; Burggraf, V., 2000:
Prostate cancer elder alert. Living with treatment choices and outcomes

Smart, C.R., 1998:
Prostate cancer facts and fiction

Grundy, D., 1999:
Prostate cancer from a patient's perspective

Stephenson, J., 1996:
Prostate cancer gene hunters track their quarry

Hull, G.W.; Mccurdy, M.A.; Nasu, Y.; Bangma, C.H.; Yang, G.; Shimura, S.; Lee, H.M.; Wang, J.; Albani, J.; Ebara, S.; Sato, T.; Timme, T.L.; Thompson, T.C., 2000:
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines

Eastham, J.A.; Chen, S.H.; Sehgal, I.; Yang, G.; Timme, T.L.; Hall, S.J.; Woo, S.L.; Thompson, T.C., 1996:
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

Nasu, Y.; Djavan, B.; Marberger, M.; Kumon, H., 1999:
Prostate cancer gene therapy: outcome of basic research and clinical trials

Reynolds, T., 1994:
Prostate cancer genetics research picks up pace

Salgaller, M.L., 2000:
Prostate cancer immunotherapy at the dawn of the new millennium

Gil-Vernet, J.M.; Gil-Vernet Sedó, J.M., 1994:
Prostate cancer in 1994

Nash, C.; Hall, C., 2002:
Prostate cancer in Arkansas

Vutuc, C.; Waldhoer, T.; Madersbacher, S.; Micksche, M.; Haidinger, G., 2001:
Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality

Celko, A.M., 1995:
Prostate cancer in Czech Republic 1959-1992. Descriptive survey

Brasso, K.; Iverson, P., 2000:
Prostate cancer in Denmark. Incidence, morbidity and mortality

Chirpaz, E.; Ménégoz, F.; Grosclaude, P.; Colonna, M.; Bénard, E.; Rambeaud, J.J., 1999:
Prostate cancer in Isère and Tarn (France) between 1985 and 1995: evolution of therapeutic indications

Hagan, R.A.; Brownson, R.C.; Simms, S.G.; Chang, J.C.; Gibson, B.B., 1994:
Prostate cancer in Missouri: a trend analysis

Fulton, J.P., 1995:
Prostate cancer in Rhode Island

Heggestad, T.; Jonsson, P.M.; Danneskiold-Samsøe, B.; Leisti, S., 1993:
Prostate cancer in Scandinavia. Variations in practice and attitude to radical treatment

Ferri, M.; Norman, R.W., 2000:
Prostate cancer in a hypogonadal male receiving androgen supplementation

Brett, T., 2001:
Prostate cancer in general practice. Results of a five year prospective clinical study in one practice

Zhu, K.; Weiss, N.S.; Stanford, J.L.; Daling, J.R.; Stergachis, A.; McKnight, B.; Brawer, M.K.; Levine, R.S., 1999:
Prostate cancer in relation to the use of electric blanket or heated water bed

Lechevallier, E.; Cormier, L.; Barrou, B.; Benoit, G.; Bensadoun, H.; Boudjema, K.; Descottes, J-L.; Doré, B.; Guy, L.; Malavaud, B.; Martin, X.; Petit, J.; Salomon, L., 2002:
Prostate cancer in renal transplant recipients

Powell, I.J., 1998:
Prostate cancer in the African American: is this a different disease?

Anonymous, 1997:
Prostate cancer in the UK

Moul, J.W.; Lipo, D.R., 2000:
Prostate cancer in the late 1990s: hormone refractory disease options

Ko, Y.J.; Bubley, G.J., 2001:
Prostate cancer in the older man

Hwang, C.S.; Smith, L.C.; Natori, Y.; Ellis, B.; Zhou, B.; Janda, K.D., 2018:
Efficacious Vaccine against Heroin Contaminated with Fentanyl

Humphrey, P.A., 1998:
Prostate cancer in the serum prostate-specific antigen era

Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Bueno Chomón, G.; Leal Hernández, F.; Bielsa Carrillo, A.; García Burgos, J., 1998:
Prostate cancer in the transition zone in sympatomatic patients with no rectal signs and negative peripheral zone biopsy

Merrill, R.M.; Brawley, O.W., 1997:
Prostate cancer incidence and mortality rates among white and black men

Chang, J.C.; Hagan, R.A.; Malone, B.R., 1995:
Prostate cancer incidence in Missouri: an updated analysis

Yamamoto, S., 2002:
Prostate cancer incidence in the world

Kinoshita, H.; Ogawa, O., 2002:
Prostate cancer incidence, mortality, and survival rates in Japan

Sarma, A.V.; Schottenfeld, D., 2002:
Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001

Gilardoni, M.B.; Rabinovich, G.A.; Oviedo, M.; Depiante-Depaoli, M., 2000:
Prostate cancer induction in autoimmune rats and modulation of T cell apoptosis

Scobie, D.B., 2002:
Prostate cancer junked

Anonymous, 2002:
Prostate cancer link to vasectomy is weak

See, W., 1995:
Prostate cancer management in older patients

Raghavan, D., 1999:
Prostate cancer management under scrutiny: one man's meta-analysis is another man's poisson

Lawrence, S.P.; Shimek, C.M.; Deutsch, J.C., 1998:
Prostate cancer masquerading as a large rectal cancer: diagnosis by endoscopic ultrasound

Harlan, J.W.; Petty, P.M.; Bostwick, D.G., 1997:
Prostate cancer masquerading as a zygomatic posttraumatic mass

Malhi-Chowla, N.; Wolfsen, H.C.; Menke, D.; Woodward, T.A., 2001:
Prostate cancer metastasizing to the small bowel

Kuo, T., 1996:
Prostate cancer metastatic to a hamartoma

Maschka, D.A.; McCulloch, T.M.; Nerad, J.A., 1996:
Prostate cancer metastatic to the orbit

Deguchi, T.; Yang, M.; Takahashi, Y.; Kawada, Y.; Doi, T., 1997:
Prostate cancer micrometastases to lymph nodes

Cohen, R.J.; Robinson, E.; McRae, C.U., 1997:
Prostate cancer mortality in New Zealand: the past and projections for the future

Haselow, D.; Remington, P., 1997:
Prostate cancer mortality increases in Wisconsin, 1979-1994

Yamamoto, S., 2001:
Prostate cancer mortality rates by prefectures in Japan

Anonymous, 2002:
Prostate cancer options expand beyond the PSA

Williams, R.D., 1997:
Prostate cancer outcomes studies--the pathway to improvement

Anonymous, 2001:
Prostate cancer patients blindsided by side effects

Anonymous, 2002:
Prostate cancer patients show 79% cure rate with prostate brachytherapy treatment

Chapman, G.B.; Elstein, A.S.; Kuzel, T.M.; Sharifi, R.; Nadler, R.B.; Andrews, A.; Bennett, C.L., 1998:
Prostate cancer patients' utilities for health states: how it looks depends on where you stand

Laniado, M.E., 1998:
Prostate cancer potentially linked to the HPC1 gene

Potosky, A.L.; Harlan, L.C.; Stanford, J.L.; Gilliland, F.D.; Hamilton, A.S.; Albertsen, P.C.; Eley, J.W.; Liff, J.M.; Deapen, D.; Stephenson, R.A.; Legler, J.; Ferrans, C.E.; Talcott, J.A.; Litwin, M.S., 1999:
Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study

Cowen, D.; Salem, N.; Ashoori, F.; Meyn, R.; Meistrich, M.L.; Roth, J.A.; Pollack, A., 2000:
Prostate cancer radiosensitization in vivo with adenovirus-mediated p53 gene therapy

Brawley, O.W.; Figueroa-Valles, N., 1998:
Prostate cancer research and the National Cancer Institute

Bruner, D.W.; Baffoe-Bonnie, A.; Miller, S.; Diefenbach, M.; Tricoli, J.V.; Daly, M.; Pinover, W.; Grumet, S.C.; Stofey, J.; Ross, E.; Raysor, S.; Balshem, A.; Malick, J.; Engstrom, P.; Hanks, G.E.; Mirchandani, I., 1999:
Prostate cancer risk assessment program. A model for the early detection of prostate cancer

Gray, J.R., 2002:
Prostate cancer risk groups and comparisons: fruitless or fruitful?

Lightfoot; Kreigr; Sass-Kortsak; Purdham; Buchan, 2000:
Prostate cancer risk. Medical history, sexual, and hormonal factors

Alexander, F.E., 2000:
Prostate cancer screening

Stattin, P.; Stenman, U.H.; Riboli, E.; Hallmans, G.; Kaaks, R., 2001:
Prostate cancer screening

Mannello, F.; Gazzanelli, G., 2001:
Prostate cancer screening

Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A., 1997:
Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990

Villers, A.; Soulié, M.; Haillot, O.; Boccon-Gibod, L., 1997:
Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers

Feingold, R.M., 2000:
Prostate cancer screening in high-risk patients

Mercer, S.L.; Goel, V.; Levy, I.G.; Ashbury, F.D.; Iverson, D.C.; Iscoe, N.A., 1997 :
Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions

Subías Loren, P.J.; Salvador Milian, M.A., 1996:
Prostate cancer screening in the primary care consultation

Snyder, C.; Schrammel, P.N.; Griffiths, C.B.; Griffiths, R.I., 1998:
Prostate cancer screening in the workplace. Employer costs

Komeda, Y.; Soga, N.; Sato, Y.; Sato, K.; Suzuki, R.; Kawamura, J., 1996:
Prostate cancer screening in total health care check--using serum PSA and AUA score

Voss, J.D.; Schectman, J.M., 2002:
Prostate cancer screening practices and beliefs

Charatan, F.B., 1998:
Prostate cancer screening reduces deaths

Anonymous, 1999:
Prostate cancer screening tests now corrected

Vanchieri, C., 1998:
Prostate cancer screening trials: fending off critics to recruit men

Wong, J.G., 1996:
Prostate cancer screening update. Should new developments change our practice?

Shimizu, N.; Yamanaka, H.; Ichinose, Y.; Saitou, Y., 1998:
Prostate cancer screening using prostate specific antigen (PSA) in Tokatsu Hospital--examination of lost-to-followup cases

Cusan, L., 1994:
Prostate cancer screening with PSA, DRE and TRUS

Lawson, D.A.; Simoes, E.J.; Sharp, D.; Murayi, T.; Hagan, R.; Brownson, R.C.; Wilkerson, J., 1998:
Prostate cancer screening--a physician survey in Missouri

Spann, S.J., 1997:
Prostate cancer screening--what's a physician to do?

Berenguer Sánchez, A., 1996:
Prostate cancer screening: an unsolved problem

Prorok, P.C.; Potosky, A.L.; Gohagan, J.K.; Kramer, B.S., 1996:
Prostate cancer screening: current issues

Greco, K.E., 1993:
Prostate cancer screening: getting your patients to follow-up

Lefevre, M.L., 1998:
Prostate cancer screening: more harm than good?

Wilt, T.J., 1998:
Prostate cancer screening: practice what the evidence preaches

Tingen, M.S.; Weinrich, S.P.; Boyd, M.D.; Weinrich, M.C., 1998:
Prostate cancer screening: predictors of participation

Greiver, M., 2001:
Prostate cancer screening: should family physicians discuss it with their patients?

Iscoe, N.A., 1998:
Prostate cancer screening: waiting for Godot

Boyden, A., 1996:
Prostate cancer screening: what general practitioners and patients need to know

Zaragoza, M.R., 1999:
Prostate cancer screening: what have we learned?

Bradley, 2000:
Prostate cancer succumbs to gene therapy

Manne, S.L., 2002:
Prostate cancer support and advocacy groups: their role for patients and family members

Richie, J.P.; Murphy, G.P.; Walther, P., 1997:
Prostate cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines

Nupponen, N.N.; Carpten, J.D., 2002:
Prostate cancer susceptibility genes: many studies, many results, no answers

Anonymous, 1998:
Prostate cancer switch may yield map of cancer machinery, targets for drugs

Yamada, T., 2002:
Prostate cancer test and medical reimbursement

Weller, D.; Pinnock, C.; Silagy, C.; Hiller, J.E.; Marshall, V.R., 1998:
Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS

Lowe, B.A., 1994:
Prostate cancer therapy

Kohr, R.M., 1997 :
Prostate cancer transmitted in an orthotopic heart transplant

Schröder, F.H.; Collette, L.; de Reijke, T.M.; Whelan, P., 2000:
Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer

Henry, A.M.; Ash, D.V., 2002:
Prostate cancer treated with brachytherapy in a group of patients who previously underwent pelvic radiotherapy for testicular cancer

Potosky, A.L.; Merrill, R.M.; Riley, G.F.; Taplin, S.H.; Barlow, W.; Fireman, B.H.; Lubitz, J.D., 1999:
Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients

Foens, C., 1996:
Prostate cancer treatment article incomplete

O'Rourke, M.E.; Germino, B.B., 1998:
Prostate cancer treatment decisions: a focus group exploration

Alexander, G.A.; Brawley, O.W., 1998:
Prostate cancer treatment outcome in blacks and whites: a summary of the literature

Davis, D.L., 1998:
Prostate cancer treatment with radioactive seed implantation

Larson, G.; Pappas, N.; Hassoun, B., 2000:
Prostate cancer treatment with ultrasound-guided transperineal brachytherapy: analysis of the treatment results of our first 150 patients

Gossmann, A.; Okuhata, Y.; Shames, D.M.; Helbich, T.H.; Roberts, T.P.; Wendland, M.F.; Huber, S.; Brasch, R.C., 1999:
Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience

Walsh, P.C., 2002:
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging

Anonymous, 2002:
Prostate cancer vaccine--Northwest Biotherapeutics: CaPVax, DC1/HRPC, DCVax--Prostate

McNeal, J.E., 1997:
Prostate cancer volume

Imbriaco, M.; Yeung, H.; Narajanan, G.; Divgi, C., 1998:
Prostate cancer with leg pain

Hayakawa, K.; Matsumoto, M.; Aoyagi, T.; Miyaji, K.; Hata, M., 2001:
Prostate cancer with multiple lung metastases in a hemodialysis patient

Gunby, P., 1997:
Prostate cancer's complexities of causation, detection, and treatment challenge researchers

Lehtonen, T., 1999:
Prostate cancer, a challenge for the next millennium

Lawson, J.S., 1998:
Prostate cancer, birthweight, and diet

Girault, Véronique., 2002:
Prostate cancer, generalized screening soon?

Raghavan, D., 1997:
Prostate cancer, populations, politicians and power

Pisters, L.L., 1996 :
Prostate cancer--adjusting the tiller

Fowler, J.E., 1996:
Prostate cancer--bench to bedside

Partin, A.W., 1996:
Prostate cancer--educating ourselves and our nonurological colleagues

Lawrence, G.; Collins, B., 1996:
Prostate cancer--evaluating cancer-free survival: regarding Hahn et al. IJROBP 34(1):41-47; 1996

Rukstalis, D.B., 1996:
Prostate cancer--in search of certain knowledge

Tretli, S.; Engeland, A.; Haldorsen, T.; Hakulinen, T.; Hörte, L.G.; Luostarinen, T.; Schou, G.; Sigvaldason, H.; Storm, H.H.; Tulinius, H.; Vaittinen, P., 1996:
Prostate cancer--look to Denmark?

Wynder, E.L.; Fair, W.R., 1996:
Prostate cancer--nutrition adjunct therapy

Theodorescu, D., 1996:
Prostate cancer--our patients' questions

Smith, J.A., 1997:
Prostate cancer--research versus clinical patient management

Miles, B.J., 1996:
Prostate cancer--staging and prognosis

Nutting, C.M.; Dearnaley, D.P., 2002:
Prostate cancer--the Royal Marsden conformal experience

Lynch, J.H., 1996:
Prostate cancer--the added factors

Ruutu, M.; Salo, J.; Nordling, S.; Rannikko, S., 1999:
Prostate cancer--the snowball is rolling

Blasko, J.C.; Lange, P.H., 1997:
Prostate cancer--the therapeutic challenge of locally advanced disease

Abi-Aad, A.S.; Opsomer, R.J., 1996:
Prostate cancer--treatment of disseminated disease

Mergner, D., 2002:
Prostate cancer--what now? How a self-help group helps coping with the illness

Grönberg, H., 2002:
Prostate cancer. A small organ with a vital function

Bolla, M.; Van Poppel, H., 1996:
Prostate cancer. An insight into screening and local treatment

Cotter, V.T., 1998:
Prostate cancer. Examining the risks and benefits of screening

Bryan, J., 1998:
Prostate cancer. It couldn't happen here

Jones, G.W., 1993:
Prostate cancer. Magnitude of the problem. American College of Surgeons database and epidemiologic study

Bagshaw, M.A.; Kaplan, I.D.; Cox, R.C., 1993:
Prostate cancer. Radiation therapy for localized disease

Anonymous, 1993:
Prostate cancer. Report of a meeting of physicians and scientists, Institute of Cancer Research and the Royal Marsden Hospital

Newton, M.; Moore, S.; Gaehle, K.E., 1994:
Prostate cancer. Staging through laparoscopic lymphadenectomy

Murphy, W.M., 1996:
Prostate cancer. The problem of prognostic factors

Zyla, G., 2002:
Prostate cancer. Unlocking its DNA secrets

Gray, R., 2000:
Prostate cancer. What men want from their family physicians

Brett, T., 2001:
Prostate cancer. What part does diet play?

Anonymous, 2001:
Prostate cancer. What you can do to lower your risk

Gambert, S.R., 2001:
Prostate cancer. When to offer screening in the primary care setting

Levy, I.G.; Iscoe, N.A.; Klotz, L.H., 1998:
Prostate cancer: 1. The descriptive epidemiology in Canada

Iscoe, N.A.; Bruera, E.; Choo, R.C., 1999:
Prostate cancer: 10. Palliative care

Trachtenberg, J.; Crook, J.; Tannock, I.F., 1999:
Prostate cancer: 11. Alternative approaches and the future of treatment

Grover, S.A.; Zowall, H.; Coupal, L.; Krahn, M.D., 1999:
Prostate cancer: 12. The economic burden

Gray, R.E.; Philbrook, A., 1999:
Prostate cancer: 13. Whose prostate is it anyway? The view from the other side of the examining table

Nam, R.K.; Jewett, M.A.; Krahn, M.D., 1998:
Prostate cancer: 2. Natural history

Gallagher, R.P.; Fleshner, N., 1998:
Prostate cancer: 3. Individual risk factors

Meyer, F.; Fradet, Y., 1998:
Prostate cancer: 4. Screening

Karakiewicz, P.I.; Aprikian, A.G., 1998:
Prostate cancer: 5. Diagnostic tools for early detection

Goldenberg, S.L.; Ramsey, E.W.; Jewett, M.A., 1998:
Prostate cancer: 6. Surgical treatment of localized disease

Warde, P.; Catton, C.; Gospodarowicz, M.K., 1998:
Prostate cancer: 7. Radiation therapy for localized disease

Hassouna, M.M.; Heaton, J.P., 1999:
Prostate cancer: 8. Urinary incontinence and erectile dysfunction

Gleave, M.E.; Bruchovsky, N.; Moore, M.J.; Venner, P., 1999:
Prostate cancer: 9. Treatment of advanced disease

Donnell, R.F., 1999:
Prostate cancer: A challenge for screening

Anonymous, 1998:
Prostate cancer: a new clue

Heyman, E.N.; Rosner, T.T., 1996:
Prostate cancer: an intimate view from patients and wives

Bissada, N.K., 2000:
Prostate cancer: an overview

Barnard, R.J.; Aronson, W.J.; Tymchuk, C.N.; Ngo, T.H., 2002:
Prostate cancer: another aspect of the insulin-resistance syndrome?

Spurgers, K.; Briones, F.; McDonnell, T.J., 2000:
Prostate cancer: another piece to the molecular puzzle

Middleton, R.G., 1997:
Prostate cancer: are we screening and treating too much?

Kurth, K.H., 1997:
Prostate cancer: are we under the lee?

Presti, J.C., 2000:
Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy

Tombal, B.; Van Cangh, P.J., 2000:
Prostate cancer: at the beginning of a new millennium

Vetrosky, D.; White, G.L., 1999:
Prostate cancer: clinical perspectives

Marzi, M.; Rosi, P.; Mearini, E.; Bracarda, S.; Cesaroni, S.; Porena, M., 2000:
Prostate cancer: correlation between local and systemic disease

Cersosimo, R.J.; Carr, D., 1996:
Prostate cancer: current and evolving strategies

Strohmeyer, T.; Effert, P., 1993:
Prostate cancer: cytogenetic and molecular biology principles

Ruiz de Burgos Moreno, J.E., 2003:
Prostate cancer: diagnosis and survival

Bauer, J.J.; Mcleod, D.G.; Moul, J.W., 1996:
Prostate cancer: diagnosis, treatment, and experience at one tertiary-care military medical center, 1989 and 1994

Stricker, P.D., 1996:
Prostate cancer: don't be too casual

Wilt, T.J., 1996:
Prostate cancer: emerging concepts

Lawrence, G.; Collins, B., 1996:
Prostate cancer: endpoints for treatment benefits-re: Schild et al. IJROBP 34:535-541; 1996

Albanes, D., 2001:
Prostate cancer: epidemiology and prevention

Kissil, D.; Lippman, A.J., 1996:
Prostate cancer: essays on decision making

Anonymous, 2000:
Prostate cancer: events before birth may affect lifelong risk

Chauvet, B.; Alfonsi, M.; de Rauglaudre, G.; Reboul, F., 2002:
Prostate cancer: has local radiation treatment had an impact on survival?

Oleson, J.R., 1993:
Prostate cancer: hot, but hot enough?

Anonymous, 1999:
Prostate cancer: is an imperfect test worth the trouble?

Brink, S., 2000:
Prostate cancer: kinder cuts mean sharper dilemmas

Sheu, M.H.; Wang, J.H.; Chen, K.K.; Chiang, H.; Teng, M.H., 1998:
Prostate cancer: local staging with endorectal magnetic resonance imaging

Scheidler, J.; Hricak, H.; Vigneron, D.B.; Yu, K.K.; Sokolov, D.L.; Huang, L.R.; Zaloudek, C.J.; Nelson, S.J.; Carroll, P.R.; Kurhanewicz, J., 1999:
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

Denham, J.W., 2002:
Prostate cancer: low alpha/beta the only consideration? In regard to Fowler, Chappell, and Ritter: the prospects for new treatments for prostate cancer

Lee, F.; Patel, H.R.H., 2002:
Prostate cancer: management and controversies

Droz, J-P.; Fléchon, A.; Terret, C., 2002:
Prostate cancer: management of advanced disease

Sadar, M.D.; Hussain, M.; Bruchovsky, N., 2000:
Prostate cancer: molecular biology of early progression to androgen independence

Schröder, F.H., 2002:
Prostate cancer: natural history and surgical treatment of localised disease

Phillips, L., 1994:
Prostate cancer: new hope, new controversy

Wilt, T., 2002:
Prostate cancer: non-metastatic

Reynolds, T., 2000:
Prostate cancer: numbers may not tell the whole story

Lesesne, J.B., 1998:
Prostate cancer: out of the closet

Nagy, V.; Valanský, L.; Sokol, L.; Petrovicová, J., 1996:
Prostate cancer: palpation versus ultrasonography

Sandler, H.M., 1998:
Prostate cancer: patient's dilemma?

Neal, A.J.; Dearnaley, D.P., 1993:
Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapy

Büchler, E.F., 2001:
Prostate cancer: prevention and patient education--wishes and demands from the viewpoint of patients

Hoey, J., 1998:
Prostate cancer: progress and perplexity

Lukka, H., 2002:
Prostate cancer: risk categories and role of hormones and radiotherapy

Cookson, M.M., 2001:
Prostate cancer: screening and early detection